MedPath

KOSELUGO

KOSELUGO

Approved
DIN Number

02530147

Drug Class

Human

Market Date

Jan 3, 2023

Company
HC

Alexion Pharma GmbH

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02530147
AIG Number0163981002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EE04 SELUMETINIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SELUMETINIB (SELUMETINIB SULFATE)Active
Strength: 25 MG
Monograph: SELUMETINIB (SELUMETINIB SULFATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.